Apply to Cambridge Angels

Apply to Cambridge Angels

Rarecan eyes up to £3m investment this year as cancer platform targets rapidly growing market

1 Mar

Written By Charlotte Kirby

Charlotte Kirby

Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification With AI-driven Drug Discovery Platform

Five Alarm Bio raises £500k to strengthen Cambridge’s anti-ageing hand